Shandong Sino-Agri United Biotechnology Co.,Ltd (SHE:003042)
China · Delayed Price · Currency is CNY 12.17
-0.01 (-0.08%)
Nov 10, 2026, 10:45 AM CST
SHE:003042 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 1,734 | 2,288 | 2,030 | 2,647 | 3,707 | 2,839 | |
Market Cap Growth | -29.82% | 12.70% | -23.30% | -28.59% | 30.60% | - |
Enterprise Value | 2,915 | 3,371 | 2,878 | 3,191 | 3,979 | 2,963 |
Last Close Price | 12.18 | 16.06 | 14.25 | 18.58 | 25.89 | 19.66 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | - | 50.69 | 28.79 |
PS Ratio | 0.88 | 1.23 | 1.01 | 1.58 | 1.92 | 1.75 |
PB Ratio | 1.58 | 1.88 | 1.50 | 1.80 | 2.21 | 1.75 |
P/TBV Ratio | 1.80 | 2.11 | 1.67 | 1.98 | 2.40 | 1.90 |
P/OCF Ratio | 29.82 | 165.11 | 19.36 | 30.46 | - | 52.17 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.47 | 1.81 | 1.43 | 1.90 | 2.06 | 1.82 |
EV/EBITDA Ratio | 43.07 | 37.08 | 46.33 | - | 16.65 | 12.28 |
EV/EBIT Ratio | - | - | - | - | 45.79 | 23.28 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 1.38 | 0.99 | 0.88 | 0.72 | 0.36 | 0.32 |
Debt / EBITDA Ratio | 22.28 | 13.23 | 19.03 | - | 2.51 | 2.16 |
Net Debt / Equity Ratio | 1.08 | 0.85 | 0.56 | 0.34 | 0.17 | -0.03 |
Net Debt / EBITDA Ratio | 17.57 | 11.44 | 12.29 | -9.14 | 1.20 | -0.23 |
Net Debt / FCF Ratio | -16.09 | -9.00 | -10.94 | -10.28 | -1.68 | 0.29 |
Asset Turnover | 0.51 | 0.48 | 0.53 | 0.46 | 0.57 | 0.59 |
Inventory Turnover | 3.47 | 3.27 | 3.48 | 2.77 | 3.13 | 3.64 |
Quick Ratio | 0.32 | 0.25 | 0.40 | 0.47 | 0.44 | 0.65 |
Current Ratio | 0.60 | 0.56 | 0.71 | 0.87 | 1.06 | 1.23 |
Return on Equity (ROE) | -18.04% | -10.61% | -8.66% | -12.21% | 4.42% | 7.52% |
Return on Assets (ROA) | -2.91% | -2.05% | -1.85% | -3.76% | 1.61% | 2.88% |
Return on Invested Capital (ROIC) | -7.97% | -5.80% | -5.56% | -11.13% | 4.91% | 8.26% |
Return on Capital Employed (ROCE) | -12.50% | -8.40% | -5.80% | -10.90% | 4.40% | 6.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -12.67% | -5.97% | -6.03% | -7.27% | 1.97% | 3.47% |
FCF Yield | -4.23% | -5.05% | -3.44% | -1.81% | -4.57% | -6.71% |
Dividend Yield | - | - | - | - | 0.38% | 0.77% |
Payout Ratio | - | - | - | - | 54.96% | 20.39% |
Buyback Yield / Dilution | 1.46% | 0.06% | 0.13% | 0.58% | -7.63% | -24.73% |
Total Shareholder Return | 1.46% | 0.06% | 0.13% | 0.58% | -7.25% | -23.96% |